Cargando…
MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma
Bladder urothelial carcinoma (BLC) is one of the most common cancers in men, and its heterogeneity challenges the treatment to cure this disease. Recently, microRNAs (miRNAs) gained promising attention as biomarkers due to their potential roles in cancer biology. Identifying survival-associated miRN...
Autores principales: | Yerukala Sathipati, Srinivasulu, Tsai, Ming-Ju, Shukla, Sanjay K., Ho, Shinn-Ying, Liu, Yi, Beheshti, Afshin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907292/ https://www.ncbi.nlm.nih.gov/pubmed/35264666 http://dx.doi.org/10.1038/s41598-022-08082-7 |
Ejemplares similares
-
Author Correction: MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2022) -
Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2016) -
Survival estimation in patients with stomach and esophageal carcinoma using miRNA expression profiles
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2022) -
Identification of the miRNA signature associated with survival in patients with ovarian cancer
por: Sathipati, Srinivasulu Yerukala, et al.
Publicado: (2021) -
Survival associated miRNA signature in patients with head and neck carcinomas
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2023)